Dermatology Foundation

What's New?
Deadline Approaching November 18
DF and MRA are co-sponsors of a new award for melanoma detection or prevention, effective July 1, 2020. More information here.
Register Now!
Reserve your space in the 2020 DF Clinical Symposia. February 5-9 in Naples, FL.
Deadline to register is December 20, 2019.
2020 Diversity Research Supplement Award Information Now Available
Instructions, form, and Opportunity List available here. Applications are due February 3, 2020.
2019 DF Research Award Recipients
Congratulations to the 2019 DF Research Awardees.
The Dermatology Foundation

Established in 1964, the Foundation is a 501(c)3 charitable organization dedicated to enabling advancements in patient care. The DF accomplishes this important work by providing research funding each year to promising early and mid-career investigators whose novel ideas have the potential to shape the future of the specialty.

Thanks to its many physician members and industry constituents over more than five decades, the DF funding has had a tremendous long-term effect on the specialty. Foundation support has helped to:

  • Deepen our understanding of diseases and conditions including psoriasis, atopic dermatitis, inflammatory dermatoses, and autoimmune skin diseases.
  • Develop innovations including topical therapies for skin cancer, outcomes research, and biologic therapies.
  • Keep talented researchers working in our field by supporting their work at critical points where private funding is the key to their continued success.

With the continued support of dermatologists, specialty societies and corporate supporters, the DF can continue to further progress in all areas of the specialty, for the benefit of patients everywhere.

John E. Harris, MD, PhD
DF Stiefel Scholar Awardee Makes Big Strides in Addressing Vitiligo

John E. Harris, MD, PhD, Associate Professor at the University of Massachusetts, is on the verge of radically transforming care for patients suffering with vitiligo, a common and disfiguring autoimmune disease with (as yet) no FDA-approved medical treatments. He has progressed rapidly in advancing knowledge of the autoimmune pathways that cause this disease and now is closing in on a treatment goal that has remained unmet—skin that remains normal after treatment is stopped.

Read more.

Survey Underscores High Impact of DF Funding

The DF's highly-competitive career development award (CDA) has launched the investigative work and careers of many researchers since it was introduced in 1990. A recent article in the Journal of the American Academy of Dermatology shares the results of a survey of CDA recipients undertaken to measure the effectiveness of this funding mechanism—and the results confirm the importance of Foundation support.

The DF's investment in CDAs over the last three decades has benefitted the entire specialty—it has supported innovations that have led to improved patient care, enabled recipients to secure more than $10 in federal funding for every dollar they received from the DF, and has helped to develop and retain an academic workforce.

Read the details.


Founded in 1964

Executive Committee
Janet A. Fairley, M.D.
President
Bruce U. Wintroub, M.D.
Chairman, Board of Trustees
Stuart R. Lessin, M.D.
Vice President
Elizabeth I. McBurney, M.D.
Secretary-Treasurer
Members at Large:
Yvonne E. Chiu, M.D.
George Cotsarelis, M.D.
Sewon Kang, M.D.
Renée J. Mathur, M.D.
Kishwer S. Nehal, M.D.
Seth J. Orlow, M.D., Ph.D.
John T. Seykora, M.D., Ph.D.
Michael D. Tharp, M.D.
Jonathan S. Weiss, M.D.
Executive Staff
Sandra Rahn Benz
Executive Director
Christine M. Boris
Deputy Executive Director
DF Office
1560 Sherman Avenue
Suite 500
Evanston, IL 60201-4806
Phone: (847) 328-2256
Fax: (847) 328-0509
Send an e-mail.